METTL1 and nasopharyngeal carcinoma: The upstream transcription factor ARNT promotes the growth of METTL1 [69], which modifies the m7G tRNA, activates the WNT/β-catenin signaling pathway, boosts epithelial-mesenchymal transition (EMT), and increases the NPC cells’ resistance to chemotherapy.